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Abstract
The syntheses of various pyrimidinones as potentially bioactive products by means of the highly controlled continuous-flow retro-
Diels–Alder reaction of condensed pyrimidinone derivatives are presented. Noteworthy, the use of this approach allowed us to
rapidly screen a selection of conditions and quickly confirm the viability of preparing the desired pyrimidinones in short reaction
times. Yields typically higher than those published earlier using conventional batch or microwave processes were achieved.
Introduction
The continuous-flow (CF) technology has gained significant
importance in modern synthetic chemistry [1-3] and becomes a
core technology in the pharmaceutical, agrochemical, and fine
chemical industries [4,5]. The use of this technology opens a
new door to a quick optimization, acceleration [6], and easy
scale-up with a wide and growing range of chemical transfor-
mations in combination with an inherently safe and green nature
[7-12]. Advantageously, safety issues are complied with excel-
lent mixing and heat transfer [7-14]. These allow the access to
elevated temperatures and pressures accredited to superheating
of organic solvents in a controlled and safe fashion [6,14-17].
The accurate tuning of residence time can further broaden the
versatility of CF processes by governing the outcome of chemi-
cal reactions, determining the reaction rate and the conversion
and by influencing product selectivities [17-19]. Thus, flow
chemistry has long been selected to provide a simple means to
use more rigorous reaction conditions and revisit difficult reac-
tions that have been neglected in the past [21].
The retro-Diels–Alder (rDA) reaction has become an important
tool for synthetic chemists in their search towards the synthesis
and design of novel heterocyclic scaffolds. This pyrolytic disso-
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ciation arises when one or both fragments are notably stable
[22]. The unsaturation present in the original starting material is
produced in the DA addition, and the same atoms are involved
in both the bond formation and cleavage steps [23-25]. The rDA
process is an efficient technique for the introduction of a double
bond into a heterocyclic skeleton [26] as well as for the enantio-
divergent [27] and the enantiocontrolled [28] syntheses of
heterocyclic compounds. The rDA products can be gained, due
to a thermal [4 + 2]-cycloreversion, by distillation under
reduced pressure [29], boiling in solvent [30,31], and applying
microwave irradiation [32-35] or flash vacuum pyrolysis
[35,36]. rDA reactions under mild conditions have been widely
examined and discussed for the laboratory preparation of
heteromonocycles or condensed-ring heterocycles [37-40].
However, the CF rDA method was introduced when Meyers’
group performed the preparation of a precursor intermediate for
the construction of diverse tetracycline antibiotics [41]. Our aim
in the present study was to synthesize functionalized pyrimidi-
none systems through rDA reactions. Many of these products
are of high importance in drug design due to their diverse bio-
logical properties including antimicrobial, antiviral, antioxidant
and antitumor activities. In addition, they are present in several
natural frameworks [42-44].
We wanted to exploit the benefits of flow processing for reac-
tion optimization and synthesis and develop novel sustainable
synthetic methodologies with possible useful applications for
the pharmaceutical industry. Our results show that the de-
veloped CF technology is superior to existing conventional
batch technologies.
Results and Discussion
The starting materials, i.e., fused tricyclic or tetracyclic pyrim-
idinones 1–8 have been previously prepared by literature
methods [26,45-50]. Cyclization of the corresponding di-exo- or
di-endo-amino acids or esters with ethyl p-chlorobenzimidate
resulted in tricyclic pyrimidinones 1, 2a and 2b [26,45-49].
Methanopyrrolo-, methanopyrido- and methanoazepino[2,1-
b]quinazolinones 3–6 were prepared by ring enlargement of
di-exo-norbornene-fused azetidinones with lactim ethers [50].
For the preparation of 2-thioxopyrimidinones 7, 8a and 8b, the
most common method is the reaction of the appropriate amino
esters with phenyl isothiocyanate, followed by cyclization of
the resulting thiourea with hydrogen chloride under reflux
[45,49]. The starting materials were selected to comprise mole-
cules where good (>80%), medium (70–80%) and no conver-
sion was observed under batch rDA conditions. Batch reactions
were carried out by the following ways: heating under neat
conditions, refluxing in solvents having a high boiling point
[chlorobenzene (CB) or 1,2-dichlorobenzene (DCB)], and under
microwave (MW) conditions in DCB.
In order to provide a rapid and efficient access to the desired
pyrimidinones 9–14 (Scheme 1), we reinvestigated these rDA
reactions by using another method involving flow chemistry.
Therefore, a modular flow system was designed, equipped with
a heated 304 stainless steel coil and an adjustable back-pressure
regulator (0–300 bar) controlling the use of solvents under
superheated conditions. The coil was heated in an oven to the
desired temperature and solutions of the starting materials 1–8
were loaded into the reactor via a HPLC pump. Solvents were
selected on the basis of the solubility of the starting materials. A
schematic representation of the flow reactor setup is illustrated
in Figure 1. Products 9–14 thus prepared were identified by
means of HPLC–MS and NMR spectroscopic analysis. All
physical and spectroscopic data of pyrimidinones 9–14 were
identical with their literature data (Supporting Information
File 1).
Scheme 1: Flow synthesis for the preparation of fused pyrimidinones
9–14 by rDA reaction. Solvent and conditions (FR is the flow rate):
(i) MeCN, toluene, FR = 0.5 mL min−1, 230–250 °C; (ii) MeOH,
FR = 0.5 mL min−1, 120–150 °C; (iii) MeCN, FR = 0.5 mL min−1,
220–250 °C.
The rDA reaction is basically a thermally-driven process.
Consequently, by careful reaction parameter optimization, a
balance should be found between the desired rDA cyclorever-
sion reaction and the unwanted thermal degradation of the rDA
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Figure 1: Schematic outline of the continuous-flow reactor.
Table 1: Reaction parameter optimization for the CF rDA reaction of 1.
entry temperature [°C] residence time [min] conversion [%] degradation product [%]
1 200 10 64 –
2 210 10 82 –
3 220 10 83 –
4 230 10 86 0
5 240 10 100 7
6 250 10 100 18
7 230 15 100 0
8 230 30 100 13
product. The conversion and yield of a reaction under CF condi-
tions is influenced directly by the residence time and reaction
temperature, which are crucial determining factors in flow
chemistry [18-20]. Thus, these two parameters were fine-tuned
for all of the starting materials. The residence time was set by
the use of coils with different lengths. The pressure and flow
rate of the reactions were kept at constant values of 10 bars and
0.5 mL min−1, respectively. The full reaction parameter optimi-
zation is shown only for compound 1 in Table 1.
The tricyclic di-exo-2-(4-chlorophenyl)tetrahydro-5,8-methano-
4(3H)-quinazoline (1) was dissolved in acetonitrile (MeCN) and
first the effect of the temperature was investigated. The results
show that with 10 min residence time the best conversion value
(86%) was obtained at 230 °C (Table 1, entry 4). It should be
noted that at higher temperature, a significant amount of degra-
dation product was observed and a brown oil was isolated
(Table 1, entries 5 and 6). To further improve the conversion,
the residence time was increased by utilizing longer coils
(Table 1, entries 7 and 8). It was found that complete conver-
sion can be obtained at 15 min residence time and the desired
rDA product was isolated with 92% yield (Table 1, entry 7,
Table 2, entry 1). With longer residence times, again, degrada-
tion of the product was observed. Importantly, the complete
reaction parameter optimization was carried out only in
105 min. The parameters of the optimized reaction conditions
and related results are summarized in Table 2.
In the case of di-endo-isomer 2a, higher temperature (250 °C)
but a shorter residence time was satisfactory to isolate 9 in a
yield of 95%. Furthermore, we proceeded to investigate the
elimination of cyclohexadiene from compound 2b. Because of
solubility reasons, the solvent was changed to toluene, which is
known to be compatible with high-temperature conditions [51-
53]. Retrodiene product 9 was afforded with full conversion and
in an excellent yield of 93%, which is higher than the maximum
yield (85%) reached in our previous batch work [54]. Impor-
tantly, this result was achieved with a residence time of 30 min.
Subsequently, tetracyclic methanopyrrolo-, methanopyrido- and
methanoazepino[2,1-b]quinazolinones 3–6 were examined.
Because of their excellent solubility, reactions were carried out
in methanol (MeOH). Importantly, much milder reaction
conditions gave satisfactory results. With the utilization of
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Table 2: Comparison between batch reactionsa and the CF process for the synthesis of pyrimidinones 9–14.
starting material product batch reaction (lit.) CF in the present work
method: yieldc [%] solventb temp [°C] residence time [min] yieldc [%]
1 9 A: 85 [47]B: 56 [46]
MeCN
230 15 92





toluene 230 30 93
3 10
B: 70–80 [50] MeOH
130 10 95
4 11 150 10 97
5 12 120 10 95
6 13 130 10 94
7 14 B: 80 [45]C: 89 [54]
MeCN
210 15 96
8a 14 B: 80 [45] 220 10 96
8b 14 A: B: C: 0 [49](no rDA occurred) 250 30 30
d
8b 15b – EtOH/H2O = 2:1 250 30 90
Batch reactiona: Method A: reflux, CB, 12 h; Method B: performed at their melting points; Method C: MW, solvent: DCB (2a), EtOH (7),
solvent-free (8b). bSolvents were selected on the basis of solubilities. cIsolated yield. dAfter column chromatography.
120–150 °C and only 10 min residence time, full conversions
and high yields (94–97%) were obtained. Lower yields were
previously found (70–80%) using a batch process, even upon
melting compounds 3–6 for 20 min [50].
The effect of the thioxo group on the rDA reaction was investi-
gated too with compounds 7, 8a and 8b. In the case of 7, a yield
of 96% was reached at full conversion at 210 °C in 15 min resi-
dence time. In the reaction of 8a, the di-endo isomer of 7, a
slightly higher temperature was necessary, while an appropriate
residence time of only 10 min was satisfactory to have 14 with
96% isolated yield.
On the basis of these encouraging results, we decided to further
examine the scope and limitation of the rDA reaction with the
use of our CF reactor. Di-endo-3-phenyl-2-thioxohexahydro-
5,8-ethanoquinazolin-4(1H)-one (8b) was selected, since this
compound did not lose cyclohexadiene to form monocyclic 14
under batch and microwave conditions [49]. A solution of 8b in
MeCN was treated in the heated coil reactor at 250 °C, with a
residence time of 30 min. Importantly, according to the
HPLC–MS analysis, compound 8b underwent thermal decom-
position but only a moderate conversion (36%) was detected
and 14 was isolated by means of column chromatography with a
yield of 30%. This result is due to the lack of the quasi-aromat-
ic character of the leaving cyclohexadiene, and possibly also
due to the temperature limitation of our system. Surprisingly,
however, we could detect traces of di-endo-3-phenyl-4a,5,8,8a-
tetrahydro-5,8-ethanoquinazolin-4(3H)-one (15b), resulting
from desulfurisation of 8b (Scheme 2). This observation
prompted us to investigate whether desulfurisation can occur
under the flow reactor conditions. In the literature, a similar de-
sulfurisation batch reaction was performed with nickel catalysis,
in ethanol (EtOH)/water (2:1) solution [55-57]. Thus, thioxo de-
rivative 8b was dissolved in this mixture, and the CF method
was repeated. Desulfurisation of 8b, at 250 °C without adding
any catalytic metal, provided tricyclic 15b in good yield (90%).
Most probably, the reaction was catalyzed by nickel, a compo-
nent of the 304 stainless steel reactor coil [58,59]. These results
also underline the importance to select appropriate solvents and
tubing [60,61] for thermally driven reactions. In support of our
results, tricyclic 15b was also prepared alternately: the mixture
of 3-aminobicyclo[2.2.2]oct-5-ene-carboxylic acid, triethyl-
orthoformate, aniline and acetic acid was subjected to micro-
wave irradiation at 120 W at 80 °C for 20 min. After comple-
tion of the reaction, as monitored by TLC, 20% methanolic
solution in water was added to get precipitation. The solid was
filtered off and washed with water to get di-endo-3-phenyl-
4a,5,8,8a-tetrahydro-5,8-ethanoquinazolin-4(3H)-one (15b). All
spectroscopic data of the alternately synthesized compound
were the same as those obtained by the flow chemical method.
The protocol for the synthesis of 15b and the 1H and 13C NMR
spectra of 15b are shown in Supporting Information File 1 of
this study.
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Scheme 2: Synthesis of tricyclic ethanoquinazolin-4(3H)-one 15b;
(i) MeCN, FR = 0.5 mL min−1, 220–250 °C; (ii) EtOH/H2O = 2:1,
FR = 0.5 mL min−1, 250 °C; (iii) MeCN, FR = 0.5 mL min−1, 250 °C.
A further attempt was made to perform the rDA reaction with
15b at 250 °C with a residence time of 15 min in MeCN. How-
ever, the formation of 16 was not observed, that is the starting
tetrahydroquinazolinone derivative 15b did not undergo a ther-
mally driven rDA reaction (Scheme 2). Furthermore, by
applying the same conditions on 14, no desulfurisation occurred
and the formation of 16 was not detected either.
Conclusion
In the case of compounds 1–8, HPLC–MS measurements
revealed full conversions to the desired pyrimidinones 9–14,
whereas only a moderate conversion of 8b to 14 was observed.
Mainly the retrodiene decomposition of compounds 1–8
occurred, since these latter possess the quasi-aromatic character,
through the splitting-off of cyclopentadiene or cyclohexadiene.
The stereochemistry (di-endo versus di-exo condensation) of the
starting pyrimidinones 1, 2, 7 and 8 has no significant effect on
the reaction yields. By using this safe, stable and scalable flow
process, pyrimidinones 9–14 were afforded in high purity with-
out the need for further purification steps. In addition, excellent
yields and shorter reaction times are significant further advan-
tages when compared to the corresponding batch processes.
Moreover, the flow technology allowed the replacement of
high-boiling and toxic solvents, which are commonly em-
ployed in batch process, e.g., CB or DCB, by less harmful, en-
vironmentally benign solvents such as toluene, MeCN, metha-
nol, and ethanol.
In summary, we have developed a simple flow-based method
for the preparation of pyrimidinone derivatives, precursors of a
series of pharmacologically active materials, through the rDA
reaction. The design of the reactor enabled accurate control of
both residence time and reaction temperature. CF syntheses
were performed under high-temperature conditions with varied
solvents. The CF reactor set-up ensured enhanced safety and
afforded yields higher than those for the batch and microwave
processes. These could be achieved through careful reaction pa-
rameter optimization. It is particularly true for 8b, which was
unreactive under batch conditions, in contrast to a yield of 30%
in CF. We envisage that this method can be readily extended to
the preparation of other synthetically important building blocks
requiring harsh conditions in batch methods. A simple, effi-
cient and scalable production was implemented with a short
processing time, which might open up new horizons for a
potential CF industrial synthesis of heterocycles.
Supporting Information
Supporting Information File 1
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